Drug Discovery Chemistry

Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic in-person and online event for medicinal and biophysical chemists working in pharma, biotech, and academia. Nearly 800 attendees participated virtually this year, with 71% of delegates from pharma/biotech and 16% from academia. 60% of attendees were scientists/technologists and 22% were executives/directors.

Speakers from the following have already confirmed their participation for April’s event, which will be available in-person to vaccinated attendees only: Amgen, Astex Pharmaceuticals, AstraZeneca, Aurigene Discovery Technologies, Bayer Pharmaceuticals, Baylor College of Medicine, Biogen, Bristol Myers Squibb, Dana Farber Cancer Institute, ETH Zurich, Fred Hutchinson Cancer Research Center, Genentech, Insilico Medicine, Merck, Novartis, Pfizer, Progenra, Scripps Research Institute, St. Jude Children’s Research Hospital, and many more.

Limited speaking opportunities are available. If you would like to be considered for a podium presentation, please submit a speaker proposal ASAP. As a reminder, attendees still have on-demand access to watch presentations, listen to Q&A panel discussions, review posters, and much more.